Cargando…

Lysophosphatidic acid, LPA: a bad boy becomes good

Detalles Bibliográficos
Autor principal:	Budnik, Lygia T
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Debate
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC155629/ https://www.ncbi.nlm.nih.gov/pubmed/12740030 http://dx.doi.org/10.1186/1477-7827-1-37

Ejemplares similares

Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA(1), LPA(2), and LPA(3)
por: Alcántara-Hernández, Rocío, et al.
Publicado: (2015)

Lysophosphatidic Acid (LPA) Signaling in Human and Ruminant Reproductive Tract
por: Wocławek-Potocka, Izabela, et al.
Publicado: (2014)

MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia
por: Plastira, Ioanna, et al.
Publicado: (2020)

Lysophosphatidic acid and its receptors LPA(1) and LPA(3) mediate paclitaxel-induced neuropathic pain in mice
por: Uchida, Hitoshi, et al.
Publicado: (2014)

AIDS, conflict and the media in Africa: risks in reporting bad data badly
por: Lowicki-Zucca, Massimo, et al.
Publicado: (2005)

The badness of death and priorities in health
por: Solberg, Carl Tollef, et al.
Publicado: (2016)

Modulation of lysophosphatidic acid (LPA) receptor activity: the key to successful neural regeneration?
por: Gross, Isabel, et al.
Publicado: (2019)

Suppressing postcollection lysophosphatidic acid metabolism improves the precision of plasma LPA quantification
por: Kano, Kuniyuki, et al.
Publicado: (2021)

Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special?
por: Balijepalli, Pravita, et al.
Publicado: (2021)

A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors
por: Su, Pan, et al.
Publicado: (2022)

Primary human endothelial cells secrete agents that reduce responsiveness to lysophosphatidic acid (LPA)
por: Park, Eun Young, et al.
Publicado: (2012)

Migration of gastric cancer cells in response to lysophosphatidic acid is mediated by LPA receptor 2
por: YANG, DEZHI, et al.
Publicado: (2013)

Lysophosphatidic acid (LPA) 18:1 transcriptional regulation of primary human gingival fibroblasts
por: Cerutis, D. Roselyn, et al.
Publicado: (2014)

LPA(3)-mediated lysophosphatidic acid signaling promotes postnatal heart regeneration in mice
por: Wang, Fang, et al.
Publicado: (2020)

Lysophosphatidic Acid Inhibits Simvastatin-Induced Myocytoxicity by Activating LPA Receptor/PKC Pathway
por: Won, Kyung-Jong, et al.
Publicado: (2020)

Dual Role of Lysophosphatidic Acid Receptor 2 (LPA(2)) in Amyotrophic Lateral Sclerosis
por: Puigdomenech-Poch, Maria, et al.
Publicado: (2021)

Lysophosphatidic acid receptors LPA(4) and LPA(6) differentially promote lymphocyte transmigration across high endothelial venules in lymph nodes
por: Hata, Erina, et al.
Publicado: (2016)

Lysophosphatidic Acid Induces Apoptosis of PC12 Cells Through LPA1 Receptor/LPA2 Receptor/MAPK Signaling Pathway
por: Zhang, Jie, et al.
Publicado: (2020)

Lysophosphatidic Acid Induced Apoptosis, DNA Damage, and Oxidative Stress in Spinal Cord Neurons by Upregulating LPA4/LPA6 Receptors
por: Yang, Yifan, et al.
Publicado: (2022)

How confidence intervals become confusion intervals
por: McCormack, James, et al.
Publicado: (2013)

Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6
por: Chryplewicz, Agnieszka, et al.
Publicado: (2019)

Autotaxin–lysophosphatidic acid–LPA (3) signaling at the embryo‐epithelial boundary controls decidualization pathways
por: Aikawa, Shizu, et al.
Publicado: (2017)

Lysophosphatidic acid LPA(1) and LPA(3) receptors play roles in the maintenance of late tissue plasminogen activator-induced central poststroke pain in mice
por: Ueda, Hiroshi, et al.
Publicado: (2018)

Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain
por: Inoue, Makoto, et al.
Publicado: (2008)

Becoming partners, retaining autonomy: ethical considerations on the development of precision medicine
por: Blasimme, Alessandro, et al.
Publicado: (2016)

When is good, good enough? Methodological pragmatism for sustainable guideline development
por: Browman, George P, et al.
Publicado: (2015)

Recent advances in understanding of various chronic pain mechanisms through lysophosphatidic acid (LPA) receptor signaling
por: Ueda, Hiroshi
Publicado: (2012)

The lysophosphatidic acid receptor LPA(4) regulates hematopoiesis-supporting activity of bone marrow stromal cells
por: Igarashi, Hidemitsu, et al.
Publicado: (2015)

CMTM8 as an LPA1-associated partner mediates lysophosphatidic acid-induced pancreatic cancer metastasis
por: Shi, Weidong, et al.
Publicado: (2021)

Lipid phosphate phosphatase inhibitors locally amplify lysophosphatidic acid LPA(1) receptor signalling in rat brain cryosections without affecting global LPA degradation
por: Aaltonen, Niina, et al.
Publicado: (2012)

Why primary care practices should become digital health information hubs for their patients
por: Baird, Aaron, et al.
Publicado: (2014)

Role of lysophosphatidic acid receptor LPA(2 )in the development of allergic airway inflammation in a murine model of asthma
por: Zhao, Yutong, et al.
Publicado: (2009)

Reducing health inequities facing boys and young men of colour in the United States
por: Smith, James A, et al.
Publicado: (2020)

Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients
por: García-Marchena, Nuria, et al.
Publicado: (2020)

Lysophosphatidic acid receptor LPA(3) prevents oxidative stress and cellular senescence in Hutchinson–Gilford progeria syndrome
por: Chen, Wei‐Min, et al.
Publicado: (2019)

Lysophosphatidic acid (LPA)-antibody (504B3) engagement detected by interferometry identifies off-target binding
por: Ray, Manisha, et al.
Publicado: (2021)

Why the Convention on the Rights of the Child must become a guiding framework for the realization of the rights of children affected by tuberculosis
por: Basu Roy, Robindra, et al.
Publicado: (2016)

Bisphosphonate use in the horse: what is good and what is not?
por: Mitchell, Alexis, et al.
Publicado: (2019)

Between being healthy and becoming comatose: the neuropsychiatric landscape of critical illness with a focus on delirium, DSM-5 and ICD-11
por: Schieveld, Jan N. M., et al.
Publicado: (2019)

LPA5 Is Abundantly Expressed by Human Mast Cells and Important for Lysophosphatidic Acid Induced MIP-1β Release
por: Lundequist, Anders, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5hr0mglm7ggld2mkhucbtq2q4c